Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Uterine Cervical Neoplasms 20Papillomavirus Infections 12Uterine Cervical Dysplasia 9Condylomata Acuminata 7Vulvar Neoplasms 4Anus Neoplasms 4Vaginal Neoplasms 3Virus Diseases 1Persistent Infection 1Neoplasms 1Neoplasm Metastasis 1Inflammatory Bowel Diseases 1Head and Neck Neoplasms 1Endometrial Neoplasms 1Crohn Disease 1Colitis, Ulcerative 1Cervical Cancer Screening 1Acquired Immunodeficiency Syndrome 1

Interventions

Fluorouracil 3Watchful Waiting 2Observation 2Cisplatin 2human papillomavirus vaccine, L1 type 16, 18 1Transurethral Resection of Prostate 1Radiotherapy 1Proctoscopy 1Papillomavirus Vaccines 1Mass Screening 1Light Coagulation 1Laser Therapy 1Isotretinoin 1Interviews as Topic 1Imiquimod 1Human Papillomavirus Recombinant Vaccine nonavalent 1Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1HIV Testing 1Focus Groups 1Data Collection 1Colposcopy 1Blood Specimen Collection 1Acetic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Acquired Immunodeficiency Syndrome × Papillomavirus Vaccines × Gynecologic × Clear all
NCT05266898 2025-04-18

AGO-Gard

Louisiana State University Health Sciences Center in New Orleans

Phase 4 Recruiting
250 enrolled
Gynecologic

Acquired Immunodeficiency Syndrome, Uterine Cervical Dysplasia, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡